비교리스트

 카트 문의
시장보고서
상품코드
1566944

임상 의사결정 지원 플랫폼 시장 : 구성요소별, 제공 형태별, 용도별, 최종사용자별 - 세계 기회 분석 및 산업 예측(2024-2033년)

Clinical Decision Support Platform Market By Component , By Delivery Mode By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
발행일: | 리서치사: Allied Market Research | 페이지 정보: 영문 216 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

임상 의사결정 지원 플랫폼 시장

임상 의사결정 지원 플랫폼 시장은 2023년 12억 달러로 평가되며, 2024년부터 2033년까지 연평균 7.3% 성장하여 2033년에는 24억 달러에 달할 것으로 예상됩니다.

임상 의사결정 지원 플랫폼은 의사결정 프로세스를 개선하여 의료 서비스 제공을 강화하기 위해 설계된 시스템입니다. 이 플랫폼은 환자 데이터와 건강 기록을 기존 데이터베이스 및 평가와 비교하여 맞춤형 권장 사항을 제공합니다. 이 플랫폼의 목적은 정확한 진단, 최적화된 치료 계획, 오류 감소, 적절한 진료의 엄격한 준수를 통해 의료 서비스 제공의 질을 향상시키는 것입니다.

다양한 지역에서 의료 및 환자 안전에 대한 지출이 증가함에 따라 임상 의사결정 지원 플랫폼 시장의 성장이 촉진되고 있습니다. 또한, 임상 의사결정 지원 플랫폼은 자원의 최적 활용을 촉진하고 불필요한 병원 재입원 사례를 줄임으로써 비용 절감을 지원하기 때문에 높은 수요를 목격하고 있습니다. 디지털 시대에는 AI와 딥러닝의 특성을 활용한 임상 의사결정 지원 플랫폼이 각광받고 있으며, AI는 대량의 데이터를 단시간에 정확하게 평가하고 해석할 수 있게 해줍니다. 또한, 딥러닝은 예측 분석, 패턴 분석, 이미지 인식을 통해 AI의 특성을 보완합니다.

그러나 필요한 리소스 및 인프라 구축과 함께 플랫폼의 설치 및 유지보수는 비용이 많이 드는 과정으로 임상 의사결정 지원 플랫폼 시장의 성장을 저해하는 요인으로 작용하고 있습니다. 또한, 이러한 플랫폼은 데이터 유출 및 사이버 공격의 위험이 높아 시장 개척에 걸림돌로 작용하고 있습니다. 예를 들어, 미국의 헬스케어 기업 체인지 헬스케어(Change Healthcare)는 2024년 2월 랜섬웨어 공격의 표적이 되어 수백만 명의 미국인의 건강 데이터가 유출되는 피해를 입었습니다.

부문별 리뷰

임상 의사결정 지원 플랫폼 시장은 구성요소, 제공 형태, 애플리케이션, 최종사용자, 지역으로 구분됩니다. 구성요소별로 시장은 소프트웨어와 서비스로 나뉩니다. 제공 형태에 따라 온프레미스와 클라우드 기반으로 나뉩니다. 애플리케이션은 약물 알레르기 경고, 임상 가이드라인, 약물-약물 상호작용, 임상 알림, 기타로 분류됩니다. 최종사용자별로는 병원, 클리닉, 외래진료센터, 학술 및 연구기관으로 분류됩니다. 지역별로는 북미, 유럽, 아시아태평양, LAMEA로 분석됩니다.

주요 조사 결과

구성요소별로는 소프트웨어 분야가 2023년 시장을 장악했습니다.

제공 모드별로는 온프레미스 부문이 2023년 시장에서 가장 높은 점유율을 차지했습니다.

용도별로는 약물-약물 상호작용 분야가 2023년 높은 시장 점유율을 차지했습니다.

최종사용자별로는 병원 부문이 2023년 시장에서 높은 점유율을 차지했습니다.

지역별로는 북미가 2023년 가장 높은 수익을 올렸습니다.

이 보고서는 사용자 정의가 가능합니다.

  • 규제 가이드라인
  • 고객의 관심사에 따른 기업 프로파일 추가
  • 기업 개요 확장 목록
  • 과거 시장 데이터
  • 상환 시나리오

목차

제1장 소개

제2장 주요 요약

제3장 시장 상황

  • 시장 정의와 범위
  • 주요 조사 결과
    • 주요 투자 기회
    • 주요 성공 전략
  • Porter's Five Forces 분석
  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 기회

제4장 임상 의사결정 지원 플랫폼 시장 : 구성요소별

  • 시장 개요
  • 소프트웨어
  • 서비스

제5장 임상 의사결정 지원 플랫폼 시장 : 제공 형태별

  • 시장 개요
  • 온프레미스
  • 클라우드 기반

제6장 임상 의사결정 지원 플랫폼 시장 : 용도별

  • 시장 개요
  • 약제 알레르기 경고
  • 임상 가이드라인
  • 약물-약물 상호작용
  • 임상 리마인더
  • 기타

제7장 임상 의사결정 지원 플랫폼 시장 : 최종사용자별

  • 시장 개요
  • 병원
  • 진료소
  • 외래 진료 센터
  • 학술연구기관

제8장 임상 의사결정 지원 플랫폼 시장 : 지역별

  • 시장 개요
  • 북미
    • 주요 시장 동향과 기회
    • 미국의 임상 의사결정 지원 플랫폼 시장
    • 캐나다의 임상 의사결정 지원 플랫폼 시장
    • 멕시코 임상 의사결정 지원 플랫폼 시장
  • 유럽
    • 주요 시장 동향과 기회
    • 프랑스의 임상 의사결정 지원 플랫폼 시장
    • 독일의 임상 의사결정 지원 플랫폼 시장
    • 이탈리아의 임상 의사결정 지원 플랫폼 시장
    • 스페인의 임상 의사결정 지원 플랫폼 시장
    • 영국의 임상 의사결정 지원 플랫폼 시장
    • 기타 유럽의 임상 의사결정 지원 플랫폼 시장
  • 아시아태평양
    • 주요 시장 동향과 기회
    • 중국의 임상 의사결정 지원 플랫폼 시장
    • 일본의 임상 의사결정 지원 플랫폼 시장
    • 인도의 임상 의사결정 지원 플랫폼 시장
    • 한국의 임상 의사결정 지원 플랫폼 시장
    • 호주의 임상 의사결정 지원 플랫폼 시장
    • 기타 아시아태평양의 임상 의사결정 지원 플랫폼 시장
  • 라틴아메리카, 중동 및 아프리카
    • 주요 시장 동향과 기회
    • 브라질의 임상 의사결정 지원 플랫폼 시장
    • 남아프리카공화국의 임상 의사결정 지원 플랫폼 시장
    • 사우디아라비아의 임상 의사결정 지원 플랫폼 시장
    • 기타 라틴아메리카, 중동 및 아프리카의 임상 의사결정 지원 플랫폼 시장

제9장 경쟁 상황

  • 소개
  • 주요 성공 전략
  • 주요 10개 기업 제품 매핑
  • 경쟁 대시보드
  • 경쟁 히트맵
  • 주요 기업의 포지셔닝(2023년)

제10장 기업 개요

  • Cerner Corporation
  • EPIC Systems Corporation
  • IBM
  • Change Healthcare Corporation
  • Medical Information Technology Inc
  • Koninklijke Philips NV
  • Siemens Healthcare
  • Allscripts Healthcare Solutions Inc.
  • Wolters Kluwer NV
  • McKesson Corporation.
ksm 24.10.29

Clinical Decision Support Platform Market

The clinical decision support platform market was valued at $1.2 billion in 2023 and is projected to reach $2.4 billion by 2033, growing at a CAGR of 7.3% from 2024 to 2033.

Clinical decision support platform is a system designed to enhance the delivery of healthcare by refining the decision-making process. The platform compares patient data & health records with the existing database & assessments and provides tailored recommendations. The aim of the platform is to elevate the quality of healthcare delivery through precise diagnoses, optimized treatment plans, reduced errors, and strict adherence to appropriate practices.

Increase in expenditure of healthcare and patient safety across different regions is driving the growth of the clinical decision support platform market. In addition, the clinical decision support platform is witnessing a high demand as it aids in cost savings by facilitating the optimal usage of resources and reducing the cases of unnecessary hospital readmissions. In the digital era, clinical decision support platforms powered by the properties of AI and deep learning are gaining prominence. AI enables the precise assessment and interpretation of loads of data in a short span of time. Moreover, deep learning complements the attributes of AI through predictive analysis, pattern analysis, and image recognition.

However, the installation and maintenance of the platform, along with the assembly of necessary resources & infrastructure is an expensive process that restraints the growth of the clinical decision support platform market. Furthermore, these platforms remain at a high risk of data breach and cyberattacks, which hampers the market development. For instance, Change Healthcare-an American healthcare company-was targeted to a ransomware attack on February 2024, risking the health data of millions of Americans due to unauthorized access.

Segment Review

The clinical decision support platform market is segmented into component, delivery mode, application, end user, and region. On the basis of component, the market is bifurcated into software and services. As per delivery mode, it is divided into on-premises and cloud based. Depending on application, it is classified into drug allergy alerts, clinical guidelines, drug-drug interactions, clinical reminders, and others. By end user, it is categorized into hospitals, clinics, ambulatory care centers, and academic & research institutes. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of component, the software segment dominated the market in 2023.

As per delivery mode, the on-premises segment acquired a high stake in the market in 2023.

Depending on application, the drug-drug interactions segment accounted for a high market share in 2023.

By end user, the hospitals segment was the highest shareholder of the market in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The major players of the global clinical decision support platform market include Cerner Corporation, EPIC Systems Corporation, IBM, Change Healthcare Corporation, Medical Information Technology Inc, Koninklijke Philips NV, Siemens Healthcare, Allscripts Healthcare Solutions Inc., Wolters Kluwer NV, and McKesson Corporation. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data
  • Reimbursement Scenario

Key Market Segments

By Component

  • Software
  • Services

By Delivery Mode

  • On-Premises
  • Cloud Based

By Application

  • Drug Allergy Alerts
  • Clinical Guidelines
  • Drug-Drug Interactions
  • Clinical Reminders
  • Others

By End User

  • Hospitals
  • Clinics
  • Ambulatory Care Centers
  • Academic and Research Institutes

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Cerner Corporation
    • EPIC Systems Corporation
    • IBM
    • Change Healthcare Corporation
    • Medical Information Technology Inc
    • Koninklijke Philips NV
    • Siemens Healthcare
    • Allscripts Healthcare Solutions Inc.
    • Wolters Kluwer NV
    • McKesson Corporation.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: CLINICAL DECISION SUPPORT PLATFORM MARKET, BY COMPONENT

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Component
  • 4.2. Software
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Services
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country

CHAPTER 5: CLINICAL DECISION SUPPORT PLATFORM MARKET, BY DELIVERY MODE

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Delivery Mode
  • 5.2. On-Premises
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Cloud Based
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country

CHAPTER 6: CLINICAL DECISION SUPPORT PLATFORM MARKET, BY APPLICATION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Application
  • 6.2. Drug Allergy Alerts
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Clinical Guidelines
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Drug-Drug Interactions
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country
  • 6.5. Clinical Reminders
    • 6.5.1. Key Market Trends, Growth Factors and Opportunities
    • 6.5.2. Market Size and Forecast, By Region
    • 6.5.3. Market Share Analysis, By Country
  • 6.6. Others
    • 6.6.1. Key Market Trends, Growth Factors and Opportunities
    • 6.6.2. Market Size and Forecast, By Region
    • 6.6.3. Market Share Analysis, By Country

CHAPTER 7: CLINICAL DECISION SUPPORT PLATFORM MARKET, BY END USER

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By End User
  • 7.2. Hospitals
    • 7.2.1. Key Market Trends, Growth Factors and Opportunities
    • 7.2.2. Market Size and Forecast, By Region
    • 7.2.3. Market Share Analysis, By Country
  • 7.3. Clinics
    • 7.3.1. Key Market Trends, Growth Factors and Opportunities
    • 7.3.2. Market Size and Forecast, By Region
    • 7.3.3. Market Share Analysis, By Country
  • 7.4. Ambulatory Care Centers
    • 7.4.1. Key Market Trends, Growth Factors and Opportunities
    • 7.4.2. Market Size and Forecast, By Region
    • 7.4.3. Market Share Analysis, By Country
  • 7.5. Academic And Research Institutes
    • 7.5.1. Key Market Trends, Growth Factors and Opportunities
    • 7.5.2. Market Size and Forecast, By Region
    • 7.5.3. Market Share Analysis, By Country

CHAPTER 8: CLINICAL DECISION SUPPORT PLATFORM MARKET, BY REGION

  • 8.1. Market Overview
    • 8.1.1 Market Size and Forecast, By Region
  • 8.2. North America
    • 8.2.1. Key Market Trends and Opportunities
    • 8.2.2. Market Size and Forecast, By Component
    • 8.2.3. Market Size and Forecast, By Delivery Mode
    • 8.2.4. Market Size and Forecast, By Application
    • 8.2.5. Market Size and Forecast, By End User
    • 8.2.6. Market Size and Forecast, By Country
    • 8.2.7. U.S. Clinical Decision Support Platform Market
      • 8.2.7.1. Market Size and Forecast, By Component
      • 8.2.7.2. Market Size and Forecast, By Delivery Mode
      • 8.2.7.3. Market Size and Forecast, By Application
      • 8.2.7.4. Market Size and Forecast, By End User
    • 8.2.8. Canada Clinical Decision Support Platform Market
      • 8.2.8.1. Market Size and Forecast, By Component
      • 8.2.8.2. Market Size and Forecast, By Delivery Mode
      • 8.2.8.3. Market Size and Forecast, By Application
      • 8.2.8.4. Market Size and Forecast, By End User
    • 8.2.9. Mexico Clinical Decision Support Platform Market
      • 8.2.9.1. Market Size and Forecast, By Component
      • 8.2.9.2. Market Size and Forecast, By Delivery Mode
      • 8.2.9.3. Market Size and Forecast, By Application
      • 8.2.9.4. Market Size and Forecast, By End User
  • 8.3. Europe
    • 8.3.1. Key Market Trends and Opportunities
    • 8.3.2. Market Size and Forecast, By Component
    • 8.3.3. Market Size and Forecast, By Delivery Mode
    • 8.3.4. Market Size and Forecast, By Application
    • 8.3.5. Market Size and Forecast, By End User
    • 8.3.6. Market Size and Forecast, By Country
    • 8.3.7. France Clinical Decision Support Platform Market
      • 8.3.7.1. Market Size and Forecast, By Component
      • 8.3.7.2. Market Size and Forecast, By Delivery Mode
      • 8.3.7.3. Market Size and Forecast, By Application
      • 8.3.7.4. Market Size and Forecast, By End User
    • 8.3.8. Germany Clinical Decision Support Platform Market
      • 8.3.8.1. Market Size and Forecast, By Component
      • 8.3.8.2. Market Size and Forecast, By Delivery Mode
      • 8.3.8.3. Market Size and Forecast, By Application
      • 8.3.8.4. Market Size and Forecast, By End User
    • 8.3.9. Italy Clinical Decision Support Platform Market
      • 8.3.9.1. Market Size and Forecast, By Component
      • 8.3.9.2. Market Size and Forecast, By Delivery Mode
      • 8.3.9.3. Market Size and Forecast, By Application
      • 8.3.9.4. Market Size and Forecast, By End User
    • 8.3.10. Spain Clinical Decision Support Platform Market
      • 8.3.10.1. Market Size and Forecast, By Component
      • 8.3.10.2. Market Size and Forecast, By Delivery Mode
      • 8.3.10.3. Market Size and Forecast, By Application
      • 8.3.10.4. Market Size and Forecast, By End User
    • 8.3.11. UK Clinical Decision Support Platform Market
      • 8.3.11.1. Market Size and Forecast, By Component
      • 8.3.11.2. Market Size and Forecast, By Delivery Mode
      • 8.3.11.3. Market Size and Forecast, By Application
      • 8.3.11.4. Market Size and Forecast, By End User
    • 8.3.12. Rest of Europe Clinical Decision Support Platform Market
      • 8.3.12.1. Market Size and Forecast, By Component
      • 8.3.12.2. Market Size and Forecast, By Delivery Mode
      • 8.3.12.3. Market Size and Forecast, By Application
      • 8.3.12.4. Market Size and Forecast, By End User
  • 8.4. Asia-Pacific
    • 8.4.1. Key Market Trends and Opportunities
    • 8.4.2. Market Size and Forecast, By Component
    • 8.4.3. Market Size and Forecast, By Delivery Mode
    • 8.4.4. Market Size and Forecast, By Application
    • 8.4.5. Market Size and Forecast, By End User
    • 8.4.6. Market Size and Forecast, By Country
    • 8.4.7. China Clinical Decision Support Platform Market
      • 8.4.7.1. Market Size and Forecast, By Component
      • 8.4.7.2. Market Size and Forecast, By Delivery Mode
      • 8.4.7.3. Market Size and Forecast, By Application
      • 8.4.7.4. Market Size and Forecast, By End User
    • 8.4.8. Japan Clinical Decision Support Platform Market
      • 8.4.8.1. Market Size and Forecast, By Component
      • 8.4.8.2. Market Size and Forecast, By Delivery Mode
      • 8.4.8.3. Market Size and Forecast, By Application
      • 8.4.8.4. Market Size and Forecast, By End User
    • 8.4.9. India Clinical Decision Support Platform Market
      • 8.4.9.1. Market Size and Forecast, By Component
      • 8.4.9.2. Market Size and Forecast, By Delivery Mode
      • 8.4.9.3. Market Size and Forecast, By Application
      • 8.4.9.4. Market Size and Forecast, By End User
    • 8.4.10. South Korea Clinical Decision Support Platform Market
      • 8.4.10.1. Market Size and Forecast, By Component
      • 8.4.10.2. Market Size and Forecast, By Delivery Mode
      • 8.4.10.3. Market Size and Forecast, By Application
      • 8.4.10.4. Market Size and Forecast, By End User
    • 8.4.11. Australia Clinical Decision Support Platform Market
      • 8.4.11.1. Market Size and Forecast, By Component
      • 8.4.11.2. Market Size and Forecast, By Delivery Mode
      • 8.4.11.3. Market Size and Forecast, By Application
      • 8.4.11.4. Market Size and Forecast, By End User
    • 8.4.12. Rest of Asia-Pacific Clinical Decision Support Platform Market
      • 8.4.12.1. Market Size and Forecast, By Component
      • 8.4.12.2. Market Size and Forecast, By Delivery Mode
      • 8.4.12.3. Market Size and Forecast, By Application
      • 8.4.12.4. Market Size and Forecast, By End User
  • 8.5. LAMEA
    • 8.5.1. Key Market Trends and Opportunities
    • 8.5.2. Market Size and Forecast, By Component
    • 8.5.3. Market Size and Forecast, By Delivery Mode
    • 8.5.4. Market Size and Forecast, By Application
    • 8.5.5. Market Size and Forecast, By End User
    • 8.5.6. Market Size and Forecast, By Country
    • 8.5.7. Brazil Clinical Decision Support Platform Market
      • 8.5.7.1. Market Size and Forecast, By Component
      • 8.5.7.2. Market Size and Forecast, By Delivery Mode
      • 8.5.7.3. Market Size and Forecast, By Application
      • 8.5.7.4. Market Size and Forecast, By End User
    • 8.5.8. South Africa Clinical Decision Support Platform Market
      • 8.5.8.1. Market Size and Forecast, By Component
      • 8.5.8.2. Market Size and Forecast, By Delivery Mode
      • 8.5.8.3. Market Size and Forecast, By Application
      • 8.5.8.4. Market Size and Forecast, By End User
    • 8.5.9. Saudi Arabia Clinical Decision Support Platform Market
      • 8.5.9.1. Market Size and Forecast, By Component
      • 8.5.9.2. Market Size and Forecast, By Delivery Mode
      • 8.5.9.3. Market Size and Forecast, By Application
      • 8.5.9.4. Market Size and Forecast, By End User
    • 8.5.10. Rest of LAMEA Clinical Decision Support Platform Market
      • 8.5.10.1. Market Size and Forecast, By Component
      • 8.5.10.2. Market Size and Forecast, By Delivery Mode
      • 8.5.10.3. Market Size and Forecast, By Application
      • 8.5.10.4. Market Size and Forecast, By End User

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top Winning Strategies
  • 9.3. Product Mapping of Top 10 Player
  • 9.4. Competitive Dashboard
  • 9.5. Competitive Heatmap
  • 9.6. Top Player Positioning, 2023

CHAPTER 10: COMPANY PROFILES

  • 10.1. Cerner Corporation
    • 10.1.1. Company Overview
    • 10.1.2. Key Executives
    • 10.1.3. Company Snapshot
    • 10.1.4. Operating Business Segments
    • 10.1.5. Product Portfolio
    • 10.1.6. Business Performance
    • 10.1.7. Key Strategic Moves and Developments
  • 10.2. EPIC Systems Corporation
    • 10.2.1. Company Overview
    • 10.2.2. Key Executives
    • 10.2.3. Company Snapshot
    • 10.2.4. Operating Business Segments
    • 10.2.5. Product Portfolio
    • 10.2.6. Business Performance
    • 10.2.7. Key Strategic Moves and Developments
  • 10.3. IBM
    • 10.3.1. Company Overview
    • 10.3.2. Key Executives
    • 10.3.3. Company Snapshot
    • 10.3.4. Operating Business Segments
    • 10.3.5. Product Portfolio
    • 10.3.6. Business Performance
    • 10.3.7. Key Strategic Moves and Developments
  • 10.4. Change Healthcare Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Key Executives
    • 10.4.3. Company Snapshot
    • 10.4.4. Operating Business Segments
    • 10.4.5. Product Portfolio
    • 10.4.6. Business Performance
    • 10.4.7. Key Strategic Moves and Developments
  • 10.5. Medical Information Technology Inc
    • 10.5.1. Company Overview
    • 10.5.2. Key Executives
    • 10.5.3. Company Snapshot
    • 10.5.4. Operating Business Segments
    • 10.5.5. Product Portfolio
    • 10.5.6. Business Performance
    • 10.5.7. Key Strategic Moves and Developments
  • 10.6. Koninklijke Philips NV
    • 10.6.1. Company Overview
    • 10.6.2. Key Executives
    • 10.6.3. Company Snapshot
    • 10.6.4. Operating Business Segments
    • 10.6.5. Product Portfolio
    • 10.6.6. Business Performance
    • 10.6.7. Key Strategic Moves and Developments
  • 10.7. Siemens Healthcare
    • 10.7.1. Company Overview
    • 10.7.2. Key Executives
    • 10.7.3. Company Snapshot
    • 10.7.4. Operating Business Segments
    • 10.7.5. Product Portfolio
    • 10.7.6. Business Performance
    • 10.7.7. Key Strategic Moves and Developments
  • 10.8. Allscripts Healthcare Solutions Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Key Executives
    • 10.8.3. Company Snapshot
    • 10.8.4. Operating Business Segments
    • 10.8.5. Product Portfolio
    • 10.8.6. Business Performance
    • 10.8.7. Key Strategic Moves and Developments
  • 10.9. Wolters Kluwer NV
    • 10.9.1. Company Overview
    • 10.9.2. Key Executives
    • 10.9.3. Company Snapshot
    • 10.9.4. Operating Business Segments
    • 10.9.5. Product Portfolio
    • 10.9.6. Business Performance
    • 10.9.7. Key Strategic Moves and Developments
  • 10.10. McKesson Corporation.
    • 10.10.1. Company Overview
    • 10.10.2. Key Executives
    • 10.10.3. Company Snapshot
    • 10.10.4. Operating Business Segments
    • 10.10.5. Product Portfolio
    • 10.10.6. Business Performance
    • 10.10.7. Key Strategic Moves and Developments
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제